Seeing Is Believing
APGE is currently covered by 12 analysts with an average price target of $133.01. This is a potential downside of $2.06 (-1.53%) from yesterday's end of day stock price of $135.07.
Apogee Therapeutics's activity chart (see below) currently has 49 price targets and 77 ratings on display. The stock rating distribution of APGE is 83.78% BUY and 16.22% HOLD.
Analysts average stock forecasts to be materialized ratio is 88.41% with an average time for these price targets to be met of 264.61 days.
Highest price target for APGE is $137, Lowest price target is $116, average price target is $133.01.
Most recent stock forecast was given by DANIELLE BRILL from TRUIST on 13-Aug-2026. First documented stock forecast 08-Aug-2023.
Currently out of the existing stock ratings of APGE, 31 are a BUY (83.78%), 6 are a HOLD (16.22%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 18-Mar-2026
$135
$-0.07 (-0.05%)
$81
2 months 14 days ago
(13-Aug-2026)
3/3 (100%)
$0.55 (0.41%)
11
Buy Since 20-Dec-2023
$137
2 months 15 days ago
(12-Aug-2026)
8/12 (66.67%)
$59.25 (76.21%)
366
Buy Since 21-Oct-2025
$135
$2.45 (1.85%)
$110
4 months 3 days ago
(24-Jun-2026)
2/3 (66.67%)
$2.31 (1.74%)
165
Buy Since 08-Aug-2023
$160
4 months 3 days ago
(24-Jun-2026)
4/5 (80%)
$87 (119.18%)
409
Buy Since 08-Aug-2023
$135
$2.45 (1.85%)
$86
4 months 3 days ago
(24-Jun-2026)
3/4 (75%)
$2.31 (1.74%)
394
What is APGE (Apogee Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on APGE (Apogee Therapeutics)?
Which analyst has the most public recommendations on APGE (Apogee Therapeutics)?
Which analyst is the currently most bullish on APGE (Apogee Therapeutics)?
Which analyst is the currently most reserved on APGE (Apogee Therapeutics)?